Published in Pragmat Obs Res on March 15, 2012
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Which deprivation? A comparison of selected deprivation indexes. J Public Health Med (1991) 10.99
Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ (1998) 6.79
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.65
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Interventions to enhance medication adherence. Cochrane Database Syst Rev (2005) 4.08
Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol (2009) 2.73
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol (2005) 2.60
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J (2006) 2.22
Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ (2011) 2.01
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol (2008) 1.99
Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology (2011) 1.97
Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol (2005) 1.88
Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol (2001) 1.63
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation (2004) 1.42
Safety of proton pump inhibitor exposure. Gastroenterology (2010) 1.37
Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation (2011) 1.33
Aspirin after myocardial infarction: the importance of over-the-counter use. Fam Pract (1998) 1.25
Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther (2010) 1.14
Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease. Br J Gen Pract (2001) 1.05
Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology (2011) 1.03
Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol (2005) 0.96
Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation. Am J Cardiovasc Drugs (2010) 0.96
Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence. Pharmacol Ther (2009) 0.86
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. J Thromb Thrombolysis (2003) 0.83
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36
Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: The VIRGO Study. J Am Coll Cardiol (2015) 1.51
Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. Drug Saf (2010) 1.09
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf (2015) 0.93
Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom. Pharmacoepidemiol Drug Saf (2015) 0.85
Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population. Invest Ophthalmol Vis Sci (2015) 0.83
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies. PLoS One (2016) 0.81
Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care. J Cardiovasc Pharmacol Ther (2014) 0.77
Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses. BMC Cardiovasc Disord (2016) 0.75
Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care. BMC Fam Pract (2016) 0.75
Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis. PLoS One (2014) 0.75
Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network. Int J Cardiol (2017) 0.75
Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding. Pharmacoepidemiol Drug Saf (2016) 0.75